RNA R&D to Revenue
Atrium Therapeutics Inc · R&D to Revenue
RNA R&D to Revenue
Latest reported510.75%period ending
RNA Quarterly R&D/Revenue (0.00% → 510.75%)
Latest values, visible window
High-resolution chart · PNG
RNA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 510.7523% | |
| 84.8332% | |
| 2,153.3178% | |
| 0% |